Tubtimsri Sukannika, Chuenbarn Tiraniti, Manmuan Suwisit
Division of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand.
Division of Pharmacology and Biopharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand.
BMC Complement Med Ther. 2025 Jan 30;25(1):34. doi: 10.1186/s12906-025-04782-5.
Plant flavonoids such as quercetin are useful for both the therapeutic and preventive care of a variety of illnesses. Nevertheless, their antitumor efficacy against KON oral cancer is still unknown. Therefore, the aim of this investigation was to examine quercetin's anti-growth, anti-migrative, and anti-invasive characteristics. The cell cycle arrest property and mitochondrial function disruption of quercetin were also investigated. Additionally, the cellular mechanism responsible for inducing apoptosis and the anti-metastasis mechanism were identified.
KON cells were treated with quercetin in order to test the anticancer activity of this compound. The MTT colorimetric assay was used to examine the cell viability of the treated cells in comparison to MRC-5 fibroblast cells. After being exposed to the detrimental effects of quercetin, the morphology of the KON cells was examined using DAPI and FDA double staining, as well as Hoechst 33,258 and AO double staining. Annexin V-FITC with a flow cytometer and DCFDA labeling were used to detect apoptosis induction and the ROS production associated with cell death. Quercetin's ability to stop the cell cycle was evaluated via PI staining and the flow cytometer. The examination included anti-proliferative, anti-migration, and anti-invasion activities. Values for the transepithelial electrical resistance, or TEER, were measured. Ultimately, the mechanisms of action of the apoptotic markers and genes implicated in the metastatic process were clarified.
Quercetin treatment reduced the vitality of KON cells and had minimal effect on MRC cells. Following quercetin treatment, the characterization of apoptosis and cell death in KON cells was observed. When quercetin was applied to KON cells, the generation of ROS increased. Furthermore, it was discovered that quercetin increased the percentage of dead cells and cell cycle arrests in the S and G2/M phases. Moreover, quercetin inhibited KON cells' capacity for migration and invasion in addition to their effects on cell stability and structure. As a result of identifying the mechanism responsible for inducing apoptosis and preventing metastasis, quercetin was found to downregulate the expression of BCL-2/BCL-XL while increasing the expression of BAX. TIMP-1 expression was upregulated while MMP-2 and MMP-9 were downregulated. Quercetin's anticancer properties and specific mechanisms of action in relation to KON cells were clarified.
Quercetin is greatly cytotoxic in oral cancer cells, triggering cells undergoing apoptosis and ROS-mediated cell death, possessing S and G2/M cell cycle arrest properties, and exhibiting anti-metastatic activities. Finally, this discovery opens up a wide range of possibilities for developing an anti-oral cancer drug and further investigating its effectiveness in vivo and in clinical trials as an alternative cancer treatment.
植物黄酮类化合物如槲皮素对多种疾病的治疗和预防护理都很有用。然而,其对KON口腔癌的抗肿瘤疗效仍不清楚。因此,本研究的目的是研究槲皮素的抗生长、抗迁移和抗侵袭特性。还研究了槲皮素的细胞周期阻滞特性和线粒体功能破坏。此外,还确定了诱导细胞凋亡的细胞机制和抗转移机制。
用槲皮素处理KON细胞以测试该化合物的抗癌活性。采用MTT比色法检测处理后细胞与MRC-5成纤维细胞相比的细胞活力。在暴露于槲皮素的有害影响后,使用DAPI和FDA双重染色以及Hoechst 33,258和AO双重染色检查KON细胞的形态。使用膜联蛋白V-FITC与流式细胞仪和DCFDA标记来检测细胞凋亡诱导和与细胞死亡相关的活性氧产生。通过PI染色和流式细胞仪评估槲皮素阻止细胞周期的能力。检查包括抗增殖、抗迁移和抗侵袭活性。测量跨上皮电阻(TEER)值。最终,阐明了凋亡标志物和参与转移过程的基因的作用机制。
槲皮素处理降低了KON细胞的活力,对MRC细胞的影响最小。槲皮素处理后,观察到KON细胞中凋亡和细胞死亡的特征。当将槲皮素应用于KON细胞时,活性氧的产生增加。此外,发现槲皮素增加了死细胞的百分比,并使细胞周期阻滞在S期和G2/M期。此外,槲皮素除了影响细胞稳定性和结构外,还抑制了KON细胞的迁移和侵袭能力。通过确定诱导细胞凋亡和预防转移的机制,发现槲皮素下调BCL-2/BCL-XL的表达,同时增加BAX的表达。TIMP-1表达上调,而MMP-2和MMP-9表达下调。阐明了槲皮素对KON细胞的抗癌特性和具体作用机制。
槲皮素对口腔癌细胞具有很强的细胞毒性,引发细胞凋亡和活性氧介导的细胞死亡,具有S期和G2/M期细胞周期阻滞特性,并表现出抗转移活性。最后,这一发现为开发抗口腔癌药物以及进一步研究其在体内和临床试验中作为替代癌症治疗方法的有效性开辟了广泛的可能性。